First, What Are These Drugs?
You might know them by names like Ozempic or Wegovy. They belong to a class of medicines called GLP-1 receptor agonists. Originally for type 2 diabetes, they are now widely used for weight management. Think of GLP-1 as a natural hormone your gut releases
after you eat. It sends a few key signals: it tells your pancreas to manage blood sugar, slows down how quickly your stomach empties, and, crucially, tells your brain you're full. These drugs mimic that natural hormone, but in a much more powerful and long-lasting way. The result is that you feel fuller faster, stay full for longer, and your appetite is significantly reduced.
Quieting the 'Food Noise'
One of the most talked-about effects of these drugs is the reduction of 'food noise'. This is the constant, background chatter in your brain about food—thinking about your next meal, craving a snack, or being unable to resist the plate of samosas in the office canteen. By acting on the brain's reward and appetite centers, GLP-1 drugs can quiet this noise. Users report that the obsessive thoughts about food diminish, making it easier to control impulsive eating. For many, this isn't just about eating less; it's about a mental freedom from the constant pull of cravings for high-calorie foods.
Beyond Burgers: What About Biryani and Barfi?
Much of the Western narrative focuses on reduced cravings for foods like burgers and pizza. But what happens when the foods in question are deeply tied to our culture? Studies and user reports show these drugs tend to reduce the appeal of high-fat, sugary, and very salty foods. For an Indian palate, this could mean a plate of biryani suddenly seems too rich, a fresh jalebi loses its immediate allure, or the desire for a second helping at a wedding feast simply isn't there. The drugs appear to dampen the brain's reward response to these highly palatable foods, making them less satisfying and easier to turn down.
The Social and Cultural Dilemma
This is where the story gets complex for India. So much of our social fabric is woven with food. We bond over chai and snacks, celebrate festivals with elaborate meals, and show love and hospitality by feeding others. A reduced appetite can create social awkwardness. How do you navigate a family dinner when you're full after just a few bites? Or a festival where refusing sweets can be misinterpreted? This loss of interest in food can be isolating in a culture where communal eating is the norm. It's a significant social side effect that goes beyond the individual's plate and can change family and community dynamics.
Not a Magic Bullet: The Reality Check
It's crucial to understand that these are powerful prescription medications, not simple lifestyle hacks. The most common side effects are gastrointestinal, including nausea, bloating, diarrhea, and constipation, especially when starting the medication. These often subside but can be significant. Furthermore, there are concerns about the loss of muscle mass along with fat if weight loss is rapid and not paired with adequate protein intake and strength training. And when the medication is stopped, the appetite and weight often return if underlying lifestyle habits haven't changed. These drugs are a tool, not a cure-all.
Availability and Cost in India
Several GLP-1 medications, including branded versions like Ozempic, Rybelsus, and Mounjaro, are available in India by prescription. Following a patent expiry in March 2026, a number of more affordable generic versions of semaglutide have also entered the market, drastically reducing the cost for some. However, prices still vary widely, from around ₹1,300 per month for some generics to over ₹14,000 for newer branded options. They are approved for type 2 diabetes and, in some cases, for chronic weight management, but a doctor's evaluation is essential to determine if they are appropriate. The Indian government has also flagged concerns about misuse and is increasing inspections to ensure these drugs are sold and used safely under medical supervision.
